Furen Group Pharmaceutical Co.,Ltd. Posted 2.8 Billion Yuan Net Loss in 2022
Listen to the full version

Furen Group Pharmaceutical Co.,Ltd. (辅仁药业集团制药股份有限公司) (600781.SH) reported a net loss of 2.8 billion yuan in 2022, narrowing 12.4% year-on-year.
Meanwhile, the company posted 1.5 billion yuan in revenue, down 2.9% year-on-year.
At the end of the reporting period, it had 6.3 billion yuan in total assets and 8.3 billion yuan in total liabilities, with a liability-to-asset ratio of 133.3%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR